Ditters, I.A.M.; van Kooten, H.A.; van der Beek, N.A.M.E.; van der Ploeg, A.T.; Huidekoper, H.H.; van den Hout, J.M.P.
Are Anti-rhGAA Antibodies a Determinant of Treatment Outcome in Adults with Late-Onset Pompe Disease? A Systematic Review. Biomolecules 2023, 13, 1414.
https://doi.org/10.3390/biom13091414
AMA Style
Ditters IAM, van Kooten HA, van der Beek NAME, van der Ploeg AT, Huidekoper HH, van den Hout JMP.
Are Anti-rhGAA Antibodies a Determinant of Treatment Outcome in Adults with Late-Onset Pompe Disease? A Systematic Review. Biomolecules. 2023; 13(9):1414.
https://doi.org/10.3390/biom13091414
Chicago/Turabian Style
Ditters, Imke A. M., Harmke A. van Kooten, Nadine A. M. E. van der Beek, Ans T. van der Ploeg, Hidde H. Huidekoper, and Johanna M. P. van den Hout.
2023. "Are Anti-rhGAA Antibodies a Determinant of Treatment Outcome in Adults with Late-Onset Pompe Disease? A Systematic Review" Biomolecules 13, no. 9: 1414.
https://doi.org/10.3390/biom13091414
APA Style
Ditters, I. A. M., van Kooten, H. A., van der Beek, N. A. M. E., van der Ploeg, A. T., Huidekoper, H. H., & van den Hout, J. M. P.
(2023). Are Anti-rhGAA Antibodies a Determinant of Treatment Outcome in Adults with Late-Onset Pompe Disease? A Systematic Review. Biomolecules, 13(9), 1414.
https://doi.org/10.3390/biom13091414
